Costs per event averted in the neoadjuvant and adjuvant settings of early triple-negative breast cancer. Olivier T, Prasad V. Ann Oncol 2023;34:723-724.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Olivier T, Prasad V. Costs per event averted in the neoadjuvant and adjuvant settings of early triple-negative breast cancer. Ann Oncol 2023;34:723-724.
PMID: 37423675